Skip to main content
ASTHAstrana Health Inc.Sell6.3·$38.34+1.36%

Astrana Health (ASTH) Q2 2026 earnings — TrendMatrix coverage

BEAT+9.6% vs estimateEPS $0.80 vs $0.73 estCurrent verdict Sell 6.3/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.80
Estimate
$0.73
Surprise
+9.6%
Score today
6.3/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Report record · Q2 2026

How the report landed

Astrana Health (ASTH) beat the $0.73 estimate with diluted EPS of $0.80 — a clear 9.6% upside surprise.

Current read · as of 2026-09-04

Where TrendMatrix's rating stands now

TrendMatrix currently rates ASTH Sell at 6.3/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +9.6% surprise compares with a +15.7% four-quarter average. Next scheduled report: 2026-11-05.

What argues against it

  • Quality below floor (3.7 < 4.0)
  • Value-trap signals (2/5): Margin compression (op margin -0.9%), High leverage (D/E 52.4)
  • Momentum score 4.5/10 — below 4.5 minimum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$38.34
Price target
$44.80
Stop
$35.73
Upside to target
+16.8%
Reward-to-risk
1.5:1

The stock trades at 46.1× trailing but 10.7× forward earnings — consensus estimates already build in a substantial earnings recovery.

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Healthcare context

ASTH at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Care Facilities
Market cap
$1.88B
P/E (fwd)
10.7
P/E (ttm)
46.1
52-week range
$18.08$51.60
Off 52-week high
25.7%
RSI (14)
41
Volume vs avg
0.28×
Score today
6.3/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks ASTH Earnings Q2 2026 earnings